R 0008/19 of 12.04.2024
- European Case Law Identifier
- ECLI:EP:BA:2024:R000819.20240412
- Date of decision
- 12 April 2024
- Case number
- R 0008/19
- Petition for review of
- -
- Application number
- 10700730.4
- IPC class
- A61P 17/00A61K 31/225A61P 25/02A61P 21/00A61K 31/215A61P 3/10A61P 13/12A61P 19/02A61P 7/06A61P 1/16A61P 5/16A61P 25/04A61P 17/06A61K 9/20A61P 37/06A61P 1/04A61P 27/02A61P 5/14A61P 37/02A61K 9/28
- Language of proceedings
- English
- Distribution
- Distributed to board chairmen and members (B)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- Abstract on EPC2000 Art 112a(2)(c)
- Application title
- PHARMACEUTICAL FORMULATION COMPRISING ONE OR MORE FUMARIC ACID ESTERS IN AN EROSION MATRIX
- Applicant name
- FWP IP APS
- Opponent name
- Generics [UK] Limited
Biogen MA Inc.
Wohldorff GmbH - Board
- -
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 112a(2)(c)European Patent Convention Art 113(1)European Patent Convention Art 56
- Keywords
- Petition for review - unallowable
- Catchword
- -
- Cited cases
- R 0001/08R 0004/08R 0012/09R 0015/10R 0015/12R 0001/13R 0008/13R 0016/13R 0004/14R 0003/15R 0005/16R 0010/17R 0005/22
- Citing cases
- T 0626/23
Order
For these reasons it is decided that:
The petition for review is rejected as unallowable.